Profitability Ratios
| Ratio |
Value |
| GP Margin |
56.3% |
| EBIT Margin |
16.5% |
| EBITDA Margin |
22.0% |
| Operating Margin |
16.4% |
| Pretax Margin |
13.0% |
| Cont. Ops Margin |
8.4% |
| Net Margin |
8.4% |
| Bottom Line Margin |
8.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.55 |
| Quick Ratio |
0.55 |
| Solvency Ratio |
0.159 |
| Cash Ratio |
0.11 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.72 |
| Forward PEG |
-0.72 |
| Price/Book |
30.03 |
| Price/Sales |
3.06 |
| Price/FCF |
26.69 |
| Price/Op Cash Flow |
15.88 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5860 |
| Debt/Equity |
5.6494 |
| Debt/Capital |
0.8496 |
| Long-Term Debt/Capital |
0.8428 |
| Financial Leverage |
9.64 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-8.41 |
| Operating Cash Flow Ratio |
0.722 |
| Operating Cash Flow/Sales |
19.3% |
| Free Cash Flow/Operating Cash Flow |
59.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.73 |
| Interest Coverage |
4.7438 |
| Short-Term Operating Cash Flow Coverage |
6.59 |
| Operating Cash Flow Coverage |
0.33 |
| Capital Expenditure Coverage |
2.47 |
| Dividend + Capital Expenditure Coverage |
1.22 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
94.6379% |
| Dividend Yield |
2.6130% |
| Dividend Yield % |
2.6130% |
| Dividend Per Share |
0.4905 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
6.14 |
| EPS |
0.518 |
| Debt/Share |
3.7438 |
| Cash/Share |
0.18 |
| Book Value/Share |
0.63 |
| Tangible BV/Share |
-2.43 |
| Equity/Share |
0.63 |
| Operating Cash Flow/Share |
1.182 |
| Capital Expenditure/Share |
0.478 |
| FCF/Share |
0.703 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.650 |
| Earnings Before Tax/EBIT |
0.790 |
| Price/Fair Value |
30.03 |
| Debt/Market Cap |
0.1881 |
| Effective Tax Rate |
35.0% |
| Enterprise Value Multiple |
16.38 |
NRC - National Research Corporation